Welcome to LookChem.com Sign In|Join Free
  • or
C28H48O6 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

220492-76-2

Post Buying Request

220492-76-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

220492-76-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 220492-76-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,4,9 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 220492-76:
(8*2)+(7*2)+(6*0)+(5*4)+(4*9)+(3*2)+(2*7)+(1*6)=112
112 % 10 = 2
So 220492-76-2 is a valid CAS Registry Number.

220492-76-2Downstream Products

220492-76-2Relevant academic research and scientific papers

Conformationally constrained analogues of diacylglycerol. 11.1 Ultrapotent protein kinase C ligands based on a chiral 5-disubstituted tetrahydro-2-furanone template

Lee, Jeewoo,Wang, Shaomeng,Milne, George W. A.,Sharma, Rajiv,Lewin, Nancy E.,Blumberg, Peter M.,Marquez, Victor E.

, p. 29 - 35 (1996)

Conformationally constrained analogues of diacylglycerol (DAG) built on a racemic 5-[(acyloxy)-methyl]-5-(hydroxymethyl)tetrahydro-2-furanone template were shown previously to have excellent binding affinities for protein kinase C (PK-C). Since the interaction of PK-C with DAG is stereospecific, it was anticipated that PK-C would bind tightly to only one enantiomeric form of the compounds constructed with this new lactone template. Separation of enantiomers by chiral HPLC was discarded due to the ease with which acyl migration occurs in these class of compounds, and a total chiral synthesis was undertaken. Prior to chemical synthesis, the selection of the "correct" enantiomeric template was predicted by a molecular conformational analysis that compared the two enantiomers of DAG in their presumed "active" conformation with the two enantiomeric lactone templates. This presumed "active" conformation for DAG was derived from a previously developed pharmacophore model that uses the molecule of a potent phorbol diester as the ideal rigid template. The results from this analysis indicated that the "correct" lactone template corresponded to the inactive (R)-isomer of DAG. This analysis also predicted that the lactone template corresponding to the active (S)-DAG enantiomer would not fit adequately into the pharmacophore. The chiral syntheses of target compounds 2, 4, and 6, constructed on the selected, and presumably "correct" lactone template, were achieved from a common bicyclic intermediate (5R,8R,9R)-8,9-O-isopropylidene-2-keto-1,7-dioxaspiro[4.4]nonane (10) that was synthesized from commercially available 1,2:3,5-di-O-isopropylidene-α-D-threo-apiofuranose (7) by a very effective spirolactonization approach. On the basis of their ability to inhibit the binding of [3H-20]phorbol 12,13-dibutyrate (PDBU) to PK-Ca, the enantiomeric ligands 2, 4, and 6 were twice as potent as the corresponding racemates. These results confirm that binding of these lactones is stereospecific and consistent with a binding mechanism similar to that of DAG.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 220492-76-2